Newsletter Archives: Endocannabinoid Deficiency

Spread the love

This article was originally sent out in our newsletter. To get informative and educational emails, please sign up below.

Written By: Melissa Cornwell / DarkHorse Delta

To Get Weekly Newsletters Submit Your Email

A recent theory by Dr. Ethan Russo proposes that a medical condition called a clinical endocannabinoid deficiency (CECD) is behind the development of many common diseases. There are several diseases this condition is purported to cause, inluding irritable bowel syndrome (IBS), fibromyalgia, and autism. The most recent statistics for the prevalence of autism in our society estimates that it occurs in 1 of every 45 births! This is a sobering and unacceptable statistic for the “greatest country on Earth.” The presence of an entire body system that has not been fully researched just begs to be the root cause of a host of many chronic “psychosomatic” diseases that we have traditionally been told is all in our head. It does not take much convincing for me to jump on board with this theory as I am one of the millions of patients who have experienced the healing produced by the much-maligned cannabis plant (which interacts with this very body system).

Endocannabinoid System
The Human Endocannabinoid System

The underpinnings of our endocannabinoid system (ECS) consist of endocannabinoids, their receptors (to which they bind), and enzymes (which break them down). These three parts of the system work with each other to keep our body systems in balance- a condition which is known as homeostasis. Anything that can throw a wrench in this check and balance process creates a situation where disease can occur. It has been proven in past studies that low levels of these endocannabinoids are found in sufferers of migraines, irritable bowel syndrome, autism, and fibromyalgia . Researchers propose that our ECS is in endocannabinoid tone when we have adequate levels of endocannabinoids circulating in our body. When there is not enough, our endocannabinoid tone is deficient, or a clinical endocannabinoid deficiency (CECD) occurs.

Our naturally occurring endocannabinoids, AEA and 2-AG, work mainly on our cannabinoid receptors called CB1 and CB2. The phytocannabinoids found in cannabis (for example THC, CBD, and others) have been demonstrated in studies to interact with these very same receptors. Taking this concept one step further, these phytocannabinoids can act as a substitute for the natural “cannabinoids” our body is not producing on its own. This is the very same concept used in the treatment of other diseases by pharmaceutical drugs such as insulin (by acting as a substitute for what the body doesn’t produce).

I look forward to an administration that is more inclined to look at the whole picture. Maybe we can finally dispel the misinformation fed to us by the leaders in the lucrative ‘war on drugs” …………………..with the cannabis plant and a whole segment of society used as the poster child.

Written By: Melissa Cornwell – DarkHorse Delta
Article Originally From Ark420 Newsletter Archives

About Christopher

Founder and designer of ARK420.com, ARCannabisLocator.com, www.CannaCook.Tv. And Co-Host of CannaCook Tv #Writer #Artist #Design #Motivator #WebDev #CannabisPatient
Are you 21 or older? This website requires you to be 21 years of age or older. Please verify your age to view the content, or click "Exit" to leave.